GW Pharmaceuticals plc is a drug manufacturers-general business based in the US. GW Pharmaceuticals shares (GWPH) are listed on the NASDAQ and all prices are listed in US Dollars. GW Pharmaceuticals employs 1,161 staff and has a trailing 12-month revenue of around 0.00.
How to buy shares in GW Pharmaceuticals
- Compare share trading platforms.Use our comparison table to help you find a platform that fits you.
- Open your brokerage account. Complete an application with your details.
- Confirm your payment details. Fund your account.
- Research the stock. Find the stock by name or ticker symbol – GWPH – and research it before deciding if it's a good investment for you.
- Purchase now or later. Buy your desired number of shares with a market order or use a limit order to delay your purchase until the stock reaches a desired price.
- Check in on your investment. Optimize your portfolio by tracking your stock.
What's in this guide?
GW Pharmaceuticals stock price (NASDAQ: GWPH)Use our graph to track the performance of GWPH stocks over time.
GW Pharmaceuticals shares at a glance
|52-week range||$87.07 - $219.57|
|50-day moving average||$218.22|
|200-day moving average||$167.56|
|Wall St. target price||$201.13|
|Dividend yield||N/A (0%)|
|Earnings per share (TTM)||$1.07|
Buy GW Pharmaceuticals shares from these brokeragesCompare special offers, low fees and a wide range of types of investments among top trading platforms.
*Signup bonus information updated weekly.
The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.
Is it a good time to buy GW Pharmaceuticals stock?
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
Is GW Pharmaceuticals under- or over-valued?
Valuing GW Pharmaceuticals stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of GW Pharmaceuticals's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.
GW Pharmaceuticals's PEG ratio
GW Pharmaceuticals's "price/earnings-to-growth ratio" can be calculated by dividing its P/E ratio by its growth – to give 0.37. A low ratio can be interpreted as meaning the shares offer better value, while a higher ratio can be interpreted as meaning the shares offer worse value.
The PEG ratio provides a broader view than just the P/E ratio, as it gives more insight into GW Pharmaceuticals's future profitability. By accounting for growth, it could also help you if you're comparing the share prices of multiple high-growth companies.
GW Pharmaceuticals financials
|Revenue TTM||$559 million|
|Gross profit TTM||$489.7 million|
|Return on assets TTM||-4.58%|
|Return on equity TTM||-9.62%|
|Market capitalisation||$6.8 billion|
TTM: trailing 12 months
Shorting GW Pharmaceuticals shares
There are currently 693,731 GW Pharmaceuticals shares held short by investors – that's known as GW Pharmaceuticals's "short interest". This figure is 5.2% up from 659,630 last month.
There are a few different ways that this level of interest in shorting GW Pharmaceuticals shares can be evaluated.
GW Pharmaceuticals's "short interest ratio" (SIR)
GW Pharmaceuticals's "short interest ratio" (SIR) is the quantity of GW Pharmaceuticals shares currently shorted divided by the average quantity of GW Pharmaceuticals shares traded daily (recently around 603244.34782609). GW Pharmaceuticals's SIR currently stands at 1.15. In other words for every 100,000 GW Pharmaceuticals shares traded daily on the market, roughly 1150 shares are currently held short.
However GW Pharmaceuticals's short interest can also be evaluated against the total number of GW Pharmaceuticals shares, or, against the total number of tradable GW Pharmaceuticals shares (the shares that aren't held by "insiders" or major long-term shareholders – also known as the "float"). In this case GW Pharmaceuticals's short interest could be expressed as 0.02% of the outstanding shares (for every 100,000 GW Pharmaceuticals shares in existence, roughly 20 shares are currently held short) or 0% of the tradable shares (for every 100,000 tradable GW Pharmaceuticals shares, roughly 0 shares are currently held short).
Such a low SIR usually points to an optimistic outlook for the share price, with fewer people currently willing to bet against GW Pharmaceuticals.
Find out more about how you can short GW Pharmaceuticals stock.
GW Pharmaceuticals share dividends
We're not expecting GW Pharmaceuticals to pay a dividend over the next 12 months.
GW Pharmaceuticals share price volatility
Over the last 12 months, GW Pharmaceuticals's shares have ranged in value from as little as $87.0655 up to $219.5696. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while GW Pharmaceuticals's is 1.6492. This would suggest that GW Pharmaceuticals's shares are more volatile than the average for this exchange and represent, relatively-speaking, a higher risk (but potentially also market-beating returns).
GW Pharmaceuticals overview
GW Pharmaceuticals plc, a biopharmaceutical company, focuses on discovering, developing, and commercializing novel therapeutics from its proprietary cannabinoid product platform in various disease areas. Its lead product is Epidiolex, an oral medicine for the treatment of seizures associated with Lennox-Gastaut syndrome, Dravet syndrome, or tuberous sclerosis complex. The company also develops and markets Sativex for the treatment of spasticity due to multiple sclerosis. In addition, it develops various product candidates for the treatment of schizophrenia, autism spectrum disorder, neuropsychiatric symptom, and neonatal hypoxic ischemic encephalopathy. It primarily operates in Europe, the United Kingdom, the United States, and internationally. GW Pharmaceuticals plc was founded in 1998 and is based in Cambridge, the United Kingdom. .
GW Pharmaceuticals in the news
Cannabis REITs: High On Growth
CV Sciences CEO Joseph Dowling - Mainstreaming Cannabinoids (Video)
Frequently asked questionsWhat percentage of GW Pharmaceuticals is owned by insiders or institutions?
Currently 0.196% of GW Pharmaceuticals shares are held by insiders and 80.351% by institutions. How many people work for GW Pharmaceuticals?
Latest data suggests 1,161 work at GW Pharmaceuticals. When does the fiscal year end for GW Pharmaceuticals?
GW Pharmaceuticals's fiscal year ends in December. Where is GW Pharmaceuticals based?
GW Pharmaceuticals's address is: Sovereign House, Cambridge, United Kingdom, CB24 9BZ What is GW Pharmaceuticals's ISIN number?
GW Pharmaceuticals's international securities identification number is: US36197T1034 What is GW Pharmaceuticals's CUSIP number?
GW Pharmaceuticals's Committee on Uniform Securities Identification Procedures number is: 36197T103
More guides on Finder
How to buy Clover Finance (CLV) in the US
This guide will show you step-by-step instructions on how to buy the Clover Finance (CLV) token as well as a list of exchanges you can trade it on.
How to buy AT-and-T (T) stock
Steps to owning and managing T, with 24-hour and historical pricing before you buy.
How to buy Hellenic Coin (HNC) in the US
This guide will show you step-by-step instructions on how to buy the Hellenic Coin (HNC) token as well as a list of exchanges you can trade it on.
How to buy Maro (MARO) in the US
This guide will show you step-by-step instructions on how to buy the Maro (MARO) token as well as a list of exchanges you can trade it on.
How to buy Ethernity Chain (ERN) in the US
This guide will show you step-by-step instructions on how to buy the Ethernity Chain (ERN) token as well as a list of exchanges you can trade it on.
How to buy Shopping.io (SPI) in the US
This guide will show you step-by-step instructions on how to buy the Shopping.io (SPI) token as well as a list of exchanges you can trade it on.
How to buy LUKSO Token (LYXE) in the US
This guide will show you step-by-step instructions on how to buy the LUKSO Token (LYXE) token as well as a list of exchanges you can trade it on.
How to buy KardiaChain (KAI) in the US
This guide will show you step-by-step instructions on how to buy the KardiaChain (KAI) token as well as a list of exchanges you can trade it on.
How to buy Neutrino USD (USDN) in the US
This guide will show you step-by-step instructions on how to buy the Neutrino USD (USDN) token as well as a list of exchanges you can trade it on.
How to buy Venus BTC (VBTC) in the US
This guide will show you step-by-step instructions on how to buy the Venus BTC (VBTC) token as well as a list of exchanges you can trade it on.
Ask an Expert